Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aescuvest is a venture capital boutique founded in 2015 in Frankfurt, Germany. The firm focuses on health technology (healthtech) investments, aiming to address real-world medical challenges through strategic investments in innovative startups. Aescuvest has established itself as a key player in the healthtech sector, with a portfolio that includes 13 companies.
The firm operates primarily in Europe and the Middle East, leveraging its expertise to identify and support startups that are pioneering advancements in healthcare. Aescuvest's rigorous selection process ensures that it invests in companies with the potential to make significant impacts in their respective fields. The firm has built a reputation for its commitment to fostering innovation in health technology.
As of now, Aescuvest manages a diverse portfolio and continues to seek out promising investment opportunities that align with its mission of improving healthcare through technology. The firm is well-positioned to capitalize on the growing demand for healthtech solutions in the global market.
Aescuvest invests in healthtech startups that address various medical challenges, with a particular emphasis on sectors such as remote monitoring, detection and diagnosis, personalized medicine, and artificial intelligence in healthcare. The firm targets early-stage companies that demonstrate innovative approaches to solving real-world healthcare issues.
Operating primarily in Europe and the Middle East, Aescuvest employs a rigorous selection process to identify promising investment opportunities. The firm seeks founders who are not only passionate about their solutions but also possess a deep understanding of the healthcare landscape. Aescuvest typically invests in companies that are at the intersection of technology and healthcare, aiming to enhance patient outcomes and streamline medical processes.
Investment sizes vary, but Aescuvest is known for its strategic approach to funding, often participating in rounds that allow for significant growth potential. The firm values collaboration and often engages in co-investment opportunities with other venture capital firms to maximize impact.
Aescuvest's portfolio consists of 13 healthtech startups, each contributing to advancements in healthcare technology. Notable companies include:
These companies are involved in various aspects of health technology, from AI applications to personalized medicine, showcasing Aescuvest's commitment to investing in innovative solutions that address pressing healthcare challenges.
Dr. Patrick Pfeffer - Partner. Dr. Pfeffer has extensive experience in health technology investments and has led numerous successful funding rounds in the sector.
Olivier Gracia - Partner. Gracia brings a wealth of knowledge in venture capital and has a strong background in healthcare innovation.
Christoph Bartoschek - Partner. Bartoschek specializes in identifying high-potential startups and has a track record of successful investments in healthtech.
Gunter Dunkel - Advisory Board. Dunkel has significant experience in healthcare management and strategy.
Michael Beckert - Advisory Board. Beckert is known for his expertise in health technology and investment strategies.
Maximilian Engelken - Advisory Board. Engelken has a strong background in healthtech startups and investment.
Markus Eckstein - Advisory Board. Eckstein provides insights into healthcare trends and investment opportunities.
Klaus Eckstein - Advisory Board. Eckstein has extensive experience in venture capital and health technology.
Helmut Nanz - Advisory Board. Nanz is known for his strategic insights in healthcare investments.
Franz Friedl - Investment Committee. Friedl has a strong background in health technology investments.
Dominik Böhler - Investment Committee. Böhler specializes in evaluating healthtech startups.
Shari Langemak - Investment Committee. Langemak has experience in venture capital and health technology.
Michael Mrochen - Investment Committee. Mrochen is known for his expertise in health technology.
Heinz Hänel - Investment Committee. Hänel has a strong background in healthcare investments.
Tajek Hassan - Investment Committee. Hassan specializes in health technology and venture capital.
Clemens Bulitta - Investment Committee. Bulitta has extensive experience in evaluating healthtech startups.
Patric Jarchow - Investment Committee. Jarchow is known for his insights into healthcare investments.
Cecile Mohr - Investment Committee. Mohr has a strong background in health technology.
Michael Friebe - Investment Committee. Friebe specializes in health technology investments.
Thomas Schlegel - Investment Committee. Schlegel has extensive experience in venture capital.
Andreas Schmidt - Investment Committee. Schmidt is known for his expertise in health technology.
Ida Beerhalter - Investment Committee. Beerhalter specializes in evaluating healthtech startups.
Udo Janssen - Investment Committee. Janssen has a strong background in healthcare investments.
To pitch Aescuvest, founders should submit their proposals through the firm's website at [aescuvest.vc](https://aescuvest.vc). A well-structured pitch deck is essential, including information on the technology, market opportunity, and team qualifications.
Response times may vary, but founders can expect to hear back within a few weeks. Aescuvest prefers warm introductions, so leveraging connections within the healthtech community can be beneficial.
In 2022, Aescuvest achieved a notable exit with the successful acquisition of Piur Imaging, a company specializing in advanced imaging solutions for healthcare.
The firm continues to expand its portfolio, actively seeking new investment opportunities in the healthtech sector across Europe and the Middle East.
Aescuvest remains committed to supporting innovative startups that address pressing healthcare challenges, positioning itself as a key player in the health technology investment landscape.
What are Aescuvest's investment criteria?
Aescuvest focuses on healthtech startups that tackle real-world medical challenges, particularly in sectors like remote monitoring, personalized medicine, and AI in healthcare. The firm looks for innovative solutions and strong founding teams.
How can I pitch to Aescuvest?
Founders can pitch Aescuvest through their website at [aescuvest.vc](https://aescuvest.vc). A well-prepared pitch deck should include details about the technology, market opportunity, and team background.
What makes Aescuvest different from other investors?
Aescuvest specializes exclusively in healthtech, allowing them to provide targeted support and insights to their portfolio companies. Their rigorous selection process ensures they invest in high-potential startups.
What is Aescuvest's geographic focus?
The firm primarily operates in Europe and the Middle East, seeking startups that can address healthcare challenges in these regions.
What is Aescuvest's typical check size?
While specific check sizes are not disclosed, Aescuvest is known for participating in early-stage funding rounds that allow for significant growth potential.
What kind of support does Aescuvest provide post-investment?
Aescuvest actively engages with its portfolio companies, offering mentorship, operational support, and access to a network of industry experts to help drive growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.